Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-12-01
著者
-
Iwase Hirotaka
Breast And Endocrine Surgery Faculty Of Medical And Pharmaceutical Science Kumamoto University
-
Arima Nobuyuki
Department Of Clinical Pathology Kumamoto City Hospital
-
Toyozumi Yasuo
Department Of Pathology Kurume University School Of Medicine
-
Nishimura Reiki
Breast And Endocrine Surgery Kumamoto City Hospital
-
Nishimura Reiki
Department Of Breast & Endocrine Surgery Kumamoto City Hospital
-
OSAKO Tomofumi
Department of Breast and Endocrine Surgery, Kumamoto City Hospital
-
Okumura Yasuhiro
Department Of Breast And Endocrine Surgery Kumamoto City Hospital
-
Okumura Yasuhiro
Department Of Breast And Endocrine Surgery Faculty Of Medical And Pharmaceutical Sciences Kumamoto U
-
Hayashi Mitsuhiro
Department Of Breast And Endocrine Surgery Kumamoto City Hospital
-
Osako Tomofumi
Department Of Breast And Endocrine Surgery Kumamoto City Hospital
-
Iwase Hirotaka
Department Of Breast And Endocrine Surgery Faculty Of Life Sciences Kumamoto University Graduate School Of Medical Sciences
-
TOYOZUMI Yasuo
Department of Clinical Pathology, Kumamoto City Hospital
関連論文
- Clinical Usefulness of Oral Combination Chemotherapy of 5'-Deoxy-5-Fluorouridine (5'-DFUR) and Cyclophosphamide for Metastatic Breast Cancer
- Immunohistochemical Evaluation of Hormone Receptor Status for Predicting Response to Endocrine Therapy in Metastatic Breast Cancer
- Immunohistochemical Analysis on Biological Markers in Ductal Carcinoma in situ of the Breast
- Comparison of Five Different Antibodies in the Immunohistochmical Assay of Estrogen Receptor α in Human Breast Cancer
- Expression of Estrogen Receptor α Exon 5 and 7 Deletion Variant in Human Breast Cancers
- Consecutively Occurring Multiple Fibroadenomas of the Breast Distinguished from Phyllodes Tumors by Clonality Analysis of Stromal Tissue
- PROSPECTIVE STUDY ON THE EFFECT OF TOREMIFENE IN PATIENTS WITH ADJUVANT ANASTROZOLE FAILURE IN POSTMENOPAUSAL BREAST CANCER
- Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Telomerase Activity Levels for Evaluating the Surgical Margin in Breast-Conserving Surgery
- Down-Regulation of the Human PRL-3 Gene Is Associated with the Metastasis of Primary Non-Small Cell Lung Cancer
- Fit and fill analysis of a newly designed femoral stem in cementless total hip arthroplasty for patients with secondary osteoarthritis
- Primary Diffuse Large B-Cell Lymphoma of the Breast
- Clinical and Pathologic Features of Fibroadenoma of the Mastopathic Type
- Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment
- Clinical Significance of Estrogen Receptor β in Breast Cancer
- Teratoid carcinosarcoma of the ovary with prominent neuroectodermal differentiation
- Ovarian yolk sac tumor with virilization during pregnancy : Immunohistochemical demonstration of Leydig cells as functioning stroma
- Myoepithelioma of soft tissue
- Endometrial stromal sarcoma of the uterus with rhabdoid features
- p33^ and Estrogen Receptor (ER) α
- Alterations and Polymorphisms of the Estrogen Receptor Gene in Breast Cancer
- The Role of Stat5 in Estrogen Receptor-Positive Breast Cancer
- Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer
- Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
- Molecular Action of the Estrogen Receptor and Hormone Dependency in Breast Cancer
- Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy : a cohort study
- Mouse mammary gland reconstitution with extrinsic gene-transferred mammary epithelial cells in vitro and in vivo
- p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer : a cohort study
- Clinicopathological features and treatment strategy for triple-negative breast cancer
- Estrogen receptor α gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients
- Advantage of Sentinel Lymph Node Biopsy Before Neoadjuvant Chemotherapy in Breast Cancer Treatment
- Current topics and perspectives in the treatment of endocrine-related cancers
- A Case Report of Paraneoplastic Neurological Syndrome Associated with Occult Breast Cancer
- Higher Plasma Vascular Endothelial Growth Factor Levels Correlate with Menopause, Overexpression of p53, and Recurrence of Breast Cancer
- An Evaluation of Predictive Factors Involved in Clinical or Pathological Response to Primary Chemotherapy in Advanced Breast Cancer
- Benefits of Medroxyprogesterone Acetate (MPA) in Advanced or Recurrent Breast Cancer with Higher Serum Concentration
- An Evaluation of DNA Polymerase α as a Prognostic Predictor in Early Breast Cancers Smaller than 2 cm
- Investigation of Factors related to Periods to Ipsilateral Breast Tumor Recurrence after Breast-conserving Surgery and Measures for Preventing Recurrence in Early Breast Cancer
- Is triple negative a prognostic factor in breast cancer?
- Overexpression of p21Waf1 Induces Apoptosis in Immortalized Human Vascular Smooth Muscle Cells
- Triple negative breast cancer : clinicopathological characteristics and treatment strategies
- Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer
- Clinical significance of basal-like subtype in triple-negative breast cancer
- Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model
- Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
- Cyclin-Dependent Kinase Inhibitor, p21Waf1, Regulates Vascular Smooth Muscle Cell Hypertrophy
- Midkine in plasma as a novel breast cancer marker
- Elevated Serum CA15-3 Levels Correlate with Positive Estrogen Receptor and Initial Favorable Outcome in Patients who Died from Recurrent Breast Cancer
- Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
- PET/CT supports breast cancer diagnosis and treatment
- The Relationship between FDG Uptake in PET Scans and Biological Behavior in Breast Cancer
- Malignant Fibrous Histiocytoma of the Heart : Case Report and Review of 46 Cases in the Literature
- Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer : time to progression and survival
- Stromal Sarcoma of the Breast with Lung Metastases Showing a Clinical Complete Response to Doxorubicin plus Ifosfamide Treatment : Report of a Case
- Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
- Extended Indication Criteria for Endoscopic Mucosal Resection of Early Gastric Cancer with Special Reference to Lymph Node Metastasis : Examination by Multivariate Analysis
- Mucocele-like tumor associated with ductal carcinoma in situ diagnosed as mucinous carcinoma by fine-needle aspiration cytology : report of a case
- Epstein-Barr Virus-Negative Classical Hodgkin's Lymphoma in a Patient with T-Cell Prolymphocytic Leukemia Treated with Fludarabine
- Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
- Pigment Epithelium-derived Factor as a New Diagnostic Marker for Melanocytic Tumors
- A Case of Malignant Lymphoma with Hemophagocytic Syndrome Presenting as Hepatic Failure.
- Biweekly paclitaxel in patients with metastatic breast cancer
- Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer
- Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of Japan